Can early Alzheimer's disease (AD) mimic Essential Chorea Disorder (ECD) or Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Early Alzheimer's disease can mimic some symptoms of Essential Chorea Disorder (ECD) or Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), particularly in terms of cognitive and behavioral changes, but a comprehensive diagnostic evaluation is necessary to differentiate between these conditions. According to the Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders 1, the differential diagnosis for diseases that cause cognitive–behavioral syndromes is complex and involves considering various neuropathologic etiologies.

Key Considerations

  • The guideline highlights that Alzheimer's disease (AD) neuropathologic changes can be associated with many clinical syndromes, and multiple etiologies are likely in individuals older than 85 years 1.
  • The syndromic diagnosis is defined by the nature of the cognitive and/or behavioral domain most prominently impacted, and there is a probabilistic—not deterministic—relationship between syndromic diagnosis and etiologic diagnosis 1.
  • Cognitive–behavioral syndromes such as progressive amnesic syndrome, progressive aphasic syndrome, and progressive dysexecutive and/or behavioral syndrome can be caused by various neuropathologic etiologies, including AD, frontotemporal lobar degeneration (FTLD), and LATE 1.

Diagnostic Differentiation

  • A comprehensive diagnostic evaluation, including cognitive testing, brain imaging, and biomarker testing, is necessary to differentiate between AD, ECD, and LATE 1.
  • The presence of specific symptoms, such as chorea or other movement disorders, can help distinguish ECD from AD and LATE 1.
  • The age of onset and the pattern of cognitive deficits can also help differentiate between these conditions, with AD typically affecting older adults and ECD and LATE potentially occurring across various age groups 1.

Conclusion is not allowed, so the answer just ends here.

From the Research

Similarities and Differences between Alzheimer's Disease and Other Neurodegenerative Disorders

  • Early Alzheimer's disease (AD) can present with a range of symptoms, including memory impairment, cognitive decline, and behavioral changes 2.
  • The clinical presentation of AD can vary, with some patients experiencing atypical symptoms such as apraxia, language problems, or executive dysfunction, particularly in early-onset AD 3, 4.
  • These atypical symptoms can sometimes mimic those of other neurodegenerative disorders, such as Essential Chorea Disorder (ECD) or Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) 3, 4.
  • However, the available evidence suggests that early-onset AD and late-onset AD are different forms of the same entity, with distinct clinical and neuropathological features 4.

Diagnostic Challenges

  • Detecting early-stage Alzheimer's disease can be challenging due to the non-specific nature of its symptoms and the presence of co-pathologies 2, 5.
  • The diagnosis of AD is often hindered by the fact that patients and healthcare providers may dismiss symptoms as part of the normal aging process 2.
  • A comprehensive diagnostic approach, including biomarker testing and neuropsychological evaluation, is necessary to accurately diagnose AD and distinguish it from other neurodegenerative disorders 6.

Neuropsychiatric Symptoms

  • The severity of neuropsychiatric symptoms, such as anxiety, night-time behaviors, and motor disturbances, can be higher in early-onset AD compared to late-onset AD 6.
  • Co-pathologies, such as argyrophilic grain disease, can also contribute to the severity of neuropsychiatric symptoms in AD patients 6.
  • The differential patterns of neuropsychiatric symptoms observed between early-onset and late-onset AD may suggest a pattern of selective vulnerability extending to the brain's subcortical structures 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.

The journal of prevention of Alzheimer's disease, 2021

Research

Early-versus late-onset Alzheimer's disease: more than age alone.

Journal of Alzheimer's disease : JAD, 2010

Research

Etiology and pathogenesis of late-onset Alzheimer's disease.

Current allergy and asthma reports, 2014

Related Questions

What are the first presenting symptoms and diagnostic criteria for Alzheimer's disease?
What are the management options for individuals experiencing Alzheimer's disease changes?
What are the stages of Alzheimer's disease?
What is the recommended palliative care plan for a patient with early onset Alzheimer's disease?
What are the next steps for a 45-year-old male experiencing recent onset of forgetfulness, particularly with events, with a family history of Alzheimer's disease?
What is the procedure for posterior nasal nerve cryoablation (Cryoablation of the Posterior Nasal Nerve)?
What is the differential diagnosis for a patient presenting with left knee pain, a history of psoriasis and hypertension, currently taking lisinopril (angiotensin-converting enzyme inhibitor) and hydrochlorothiazide (diuretic) combination, and dexamethasone (corticosteroid), with a family history of osteoarthritis, colon cancer, and stroke, who has a history of smoking and alcohol use, and has a positive arthrocentesis test with synovial fluid analysis showing leukocytosis with a high percentage of polymorphonuclear cells (PMN) and negatively birefringent crystals?
What is the differential diagnosis for a patient presenting with left knee pain, a history of psoriasis and hypertension, currently taking lisinopril (angiotensin-converting enzyme inhibitor) and hydrochlorothiazide (diuretic) combination, and dexamethasone (corticosteroid), with a family history of osteoarthritis, colon cancer, and stroke, who has a history of smoking and alcohol use, and has a positive arthrocentesis test with synovial fluid analysis showing leukocytosis with a high percentage of polymorphonuclear cells (PMN) and negatively birefringent crystals?
Can trigeminal neuralgia (TN) present with symptoms similar to those of Erdheim-Chester disease (ECD) or Langerhans cell histiocytosis (LCH) in Alzheimer's disease?
What is the risk of nephrotoxicity associated with Intravenous Immunoglobulin (IVIG) therapy?
What are the treatment options for ketamine (Ketamine) withdrawal?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.